Special Announcement from New Pharma Thinkers

Due to the recent success of New Pharma Thinkers, we are excited to announce that Wilson Sonsini Goodrich & Rosati, one of the industry’s top legal advisors, has partnered with New Pharma Thinkers.

Online PR News – 23-November-2012 – Toronto, Ontario – As a result of this exciting partnership, we would like to offer immediate savings to our members to express our gratitude for their support. We are now offering Big Thinker memberships at the new low price of $5 per month—a discount of nearly 85 percent off the original subscription price!

We’d like to encourage as many people as possible to take advantage of this premium membership offer, so in addition to offering 85% off the subscription rate, we are offering prospective members a no-risk, 15-day free trial.

Free Regular Thinkers will continue to provide news, information on events, and special offers, but to access articles, you will need to upgrade to the $5/month plan. Trust us and our thousands of members, it’s worth it!

To take advantage of this latest offer, please visit www.newpharmathinkers.com.

Wilson Sonsini Goodrich & Rosati is the premier legal advisor to technology, life sciences, and growth enterprises worldwide. We represent companies at every stage of development, from entrepreneurial start-ups to multibillion-dollar global corporations, as well as the venture firms, private equity firms, and investment banks that finance and advise them. The firm's broad range of services and practice areas are focused on addressing the principal challenges faced by the management, boards of directors, shareholders, and in-house counsel of our clients.

In today's fast-growing, highly regulated generic pharmaceutical market, companies increasingly require specialized legal guidance as their products are developed, launched, and litigated. Wilson Sonsini Goodrich & Rosati's interdisciplinary global generics practice was created specifically to address this need, and provides sophisticated representation far beyond the scope of general corporate and securities counsel. We have assembled a highly experienced team of experts from a cross-section of the firm's key practice areas, including intellectual property, litigation, antitrust, FDA/regulatory, technology transactions, export controls and FCPA, trade secrets and employee mobility, and trademarks, copyrights, and advertising.

To learn more about Wilson Sonsini Goodrich & Rosati and its global generics practice, please visit www.wsgr.com/globalgenerics/.

New Pharma Thinkers is an industry engagement brand for Generic Pharma 2.0 Inc. (GP2.0). GP2.0 is a global consulting and communications company that has run businesses in the pharmaceutical industry since 1997. Its industry understanding is matched only by its vision of its future, which is one of change. Since 2008, GP2.0 has been focused on utilizing new media to grow its business worldwide.

Today, it’s hard for anyone operating in the generic sector to not know of one or more of GP2.0’s divisions. In constant discussion with its client base, GP2.0 has been convinced that there is a real need for a rich media platform to engage, educate, and excite the industry. The current options are outdated and lifeless; New Pharma Thinkers is a fresh and much-needed introduction to these media channels for a massive industry. GP2.0 is building something bold, pushing into “pharmerging markets” and helping partners ready themselves for the future.